Dókus, L.E.; Lajkó, E.; Ranđelović, I.; Mező, D.; Schlosser, G.; Kőhidai, L.; Tóvári, J.; Mező, G.
Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer. Pharmaceutics 2020, 12, 576.
https://doi.org/10.3390/pharmaceutics12060576
AMA Style
Dókus LE, Lajkó E, Ranđelović I, Mező D, Schlosser G, Kőhidai L, Tóvári J, Mező G.
Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer. Pharmaceutics. 2020; 12(6):576.
https://doi.org/10.3390/pharmaceutics12060576
Chicago/Turabian Style
Dókus, Levente E., Eszter Lajkó, Ivan Ranđelović, Diána Mező, Gitta Schlosser, László Kőhidai, József Tóvári, and Gábor Mező.
2020. "Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer" Pharmaceutics 12, no. 6: 576.
https://doi.org/10.3390/pharmaceutics12060576
APA Style
Dókus, L. E., Lajkó, E., Ranđelović, I., Mező, D., Schlosser, G., Kőhidai, L., Tóvári, J., & Mező, G.
(2020). Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer. Pharmaceutics, 12(6), 576.
https://doi.org/10.3390/pharmaceutics12060576